Global Expansion Will Continue With MindBody GLP-1 System And New Leadership

AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Published
14 Feb 25
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
US$18.00
30.1% undervalued intrinsic discount
31 Jul
US$12.58
Loading
1Y
70.8%
7D
-4.2%

Author's Valuation

US$18.0

30.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 46%

Shared on23 Apr 25
Fair value Increased 101%

AnalystConsensusTarget has increased revenue growth from 7.5% to 12.6%, increased future PE multiple from 13.7x to 21.5x and decreased shares outstanding growth rate from 0.0% to -0.0%.

Shared on17 Apr 25
Fair value Decreased 50%

AnalystConsensusTarget has decreased revenue growth from 12.6% to 7.5%, decreased future PE multiple from 21.5x to 13.7x and increased shares outstanding growth rate from -0.0% to 0.0%.

Shared on09 Apr 25
Fair value Increased 87%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 44%

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on13 Mar 25
Fair value Increased 9.08%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.